Trial · NCT03346200
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mammograpic Density Change | 20 mg Tamoxifen | -9.6 | 95% Confidence Interval -14.8 to -4.5 | Percentage of change | |
| Mammograpic Density Change | 10 mg Tamoxifen | -6.8 | 95% Confidence Interval -11.8 to -1.7 | Percentage of change | |
| Mammograpic Density Change | 5 mg Tamoxifen | -1.0 | 95% Confidence Interval -6.2 to 4.1 | Percentage of change | |
| Mammograpic Density Change | 2.5 mg Tamoxifen | -6.9 | 95% Confidence Interval -12.1 to -1.8 | Percentage of change | |
| Mammograpic Density Change | 1 mg Tamoxifen | -1.0 | 95% Confidence Interval -6.1 to 4.1 | Percentage of change | |
| Mammograpic Density Change | 0 mg Tamoxifen | 0.1 | 95% Confidence Interval -4.9 to 5.1 | Percentage of change | |
| Level of Side Effects | 20 mg Tamoxifen | 2.71 | 95% Confidence Interval 2.29 to 3.13 | Likert score change in Top5 Symptoms | |
| Level of Side Effects | 10 mg Tamoxifen | 2.97 | 95% Confidence Interval 2.50 to 3.45 | Likert score change in Top5 Symptoms | |
| Level of Side Effects | 5 mg Tamoxifen | 2.52 | 95% Confidence Interval 2.07 to 2.97 | Likert score change in Top5 Symptoms | |
| Level of Side Effects | 2.5 mg Tamoxifen | 2.39 | 95% Confidence Interval 1.94 to 2.85 | Likert score change in Top5 Symptoms | |
| Level of Side Effects | 1 mg Tamoxifen | 1.65 | 95% Confidence Interval 1.24 to 2.06 | Likert score change in Top5 Symptoms | |
| Level of Side Effects | 0 mg Tamoxifen | 0.36 | 95% Confidence Interval 0.32 to 0.68 | Likert score change in Top5 Symptoms | |
| Drop Out Level | 20 mg Tamoxifen | 65 | Participants | ||
| Drop Out Level | 10 mg Tamoxifen | 69 | Participants | ||
| Drop Out Level | 5 mg Tamoxifen | 79 | Participants | ||
| Drop Out Level | 2.5 mg Tamoxifen | 71 | Participants | ||
| Drop Out Level | 1 mg Tamoxifen | 58 | Participants | ||
| Drop Out Level | 0 mg Tamoxifen | 53 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03346200/results